Limited research has shown the potential of amino acid PET imaging based radiomics analysis in glioma noninvasive grading, prognostication, pseudoprogression differentiation and molecular markers prediction such as IDH mutation (15–21). The gene discussed is IDH1; the disease is central nervous system cancer.